Sp441
EXPLORING THE ROLE OF THE MICROBIOME IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND METABOLIC SYNDROME: PERSPECTIVES FROM RENOWNED EXPERTS
Date
May 19, 2024
Explore related products in the following collection:
Presenters
University of Wisconsin-Madison
University of California San Diego
Tracks
Related Products
A BLOOD-BASED BIOMARKER PANEL FOR NON-INVASIVE DIAGNOSIS OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form metabolic dysfunction-associated steatohepatitis (MASH) are highly prevalent worldwide. However, current non-invasive diagnostic approaches for MASLD and MASH are suboptimal…
